Georg Anker

Title: Georg Anker: Innovator in Pharmaceutical Composition

Introduction

Georg Anker is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical compositions.

Latest Patents

Anker holds a patent for a stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof. This invention relates to a stable pharmaceutical composition comprising amorphous or crystalline linagliptin or a pharmaceutically acceptable salt of linagliptin, mannitol, copovidone, and magnesium stearate. The patent also includes processes for preparing the stable pharmaceutical composition and a container comprising the stable pharmaceutical composition.

Career Highlights

Georg Anker is associated with Sandoz AG, a leading global healthcare company. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medication stability and efficacy.

Collaborations

Anker has collaborated with notable colleagues such as Franz Xaver Schwarz and Johann Bacher. Their combined expertise has furthered the development of effective pharmaceutical solutions.

Conclusion

Georg Anker's contributions to pharmaceutical innovation highlight his role as a key inventor in the industry. His patent for a stable pharmaceutical composition demonstrates his commitment to improving healthcare solutions.